1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D9715D72AAA6CFF065257E120015D608
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-21st-century-cures-initiative-leads-the-way-for-change-five-regulatory-issues-you-need-to-know-about?opendocument
18
19opendocument
2035.172.195.49
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




Products & Services

21st Century Cures Initiative Leads the Way For Change: Five Regulatory Issues You Need to Know About

Whitepaper Image

ID: BEB-58


Pages/Slides: 8


Published: 2015


Delivery Format: PDF


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
Please click on "Buy Now" to obtain the white paper on "21st Century Cures Initiative Leads the Way For Change: Five Regulatory Issues You Need to Know About"

“21st Century Cures Initiative” is poised to dramatically alter the way pharmaceutical and medical device products are developed and marketed in the US. The initiative pushes to reform and expedite the discovery, development and delivery of drugs and devices.

If enacted, the 21st Century Cures Act will drive drastic regulatory and policy changes within the pharmaceutical industry. This has pushed regulatory leaders to consider how their organizations should alter their operations to accommodate the regulatory changes contained in the bill.

This white paper from Best Practices, LLC addresses the five regulatory issues that carry the most implications and also have the greatest chance of being enacted into law.

Industries Profiled:
Consulting; Biotech; Medical Device; Pharmaceutical; Diagnostic; Clinical Research


Companies Profiled:
Pharma; Biotech; Medical Device Companies